Systematic review: symptom assessment using patient-reported outcomes in gastroesophageal reflux disease and dyspepsia

References

• Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004;22:108–14.
   PubMed Web of Science ®Google Scholar
• Liker H, Hungin AP, Wiklund I. Management of reflux disease in primary care: the patient perspective. J Am Board Fam Pract 2005;18:393–400.
   PubMedGoogle Scholar
• Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. Am J Med 2010;123:358–66; e2.
   PubMed Web of Science ®Google Scholar
• Halling K, Kulich K, Carlsson J, Wiklund I. An international comparison of the burden of illness in patients with dyspepsia. Dig Dis 2008;26:264–73.
   PubMedGoogle Scholar
• McColl E, Junghard O, Wiklund I, Revicki D. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients? Am J Gastroenterol 2005;100:11–18.
   PubMedGoogle Scholar
• Fransen GA, Janssen MJ, Muris JW, Mesters I, Knottnerus JA. Measuring the severity of upper gastrointestinal complaints: does GP assessment correspond with patients' self-assessment? Fam Pract 2007;24:252–8.
   PubMedGoogle Scholar
• Shaw M, Dent J, Beebe T, Junghard O, Wiklund I, Lind T, The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 2008;6:31.
   PubMed Web of Science ®Google Scholar
• Dorval E, Rey JF, Soufflet C, Halling K, Barthelemy P. Perspectives on gastroesophageal reflux disease in primary care: the REFLEX study of patient-physician agreement. BMC Gastroenterol 2011;11:25.
   PubMedGoogle Scholar
• Chassany O, Le-Jeunne P, Duracinsky M, Schwalm MS, Mathieu M. Discrepancies between patient-reported outcomes and clinician-reported outcomes in chronic venous disease, irritable bowel syndrome, and peripheral arterial occlusive disease. Value Health 2006;9:39–46.
   PubMed Web of Science ®Google Scholar
• Bijkerk CJ, de Wit NJ, Stalman WA, Knottnerus JA, Hoes AW, Muris JW. Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management. Can J Gastroenterol 2003;17:363–8; quiz 405–6.
   PubMed Web of Science ®Google Scholar
• Patient-reported outcome measures: use in medical product development to support labeling claims Rockville, USA: Food and Drug Administration. 2009. Available from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf (Accessed 9 January 2012).
   Google Scholar
• Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009;30:1030–8.
   PubMed Web of Science ®Google Scholar
• McColl E. Best practice in symptom assessment: a review. Gut 2004;53:iv49–54.
   PubMed Web of Science ®Google Scholar
• Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin 2009;25:929–42.
   PubMed Web of Science ®Google Scholar
• Stanghellini V. Review Article: pain versus discomfort--is differentiation clinically useful? Aliment Pharmacol Ther 2001;15:145–9.
   PubMedGoogle Scholar
• Wyrwich KW, Tardino VM. A blueprint for symptom scales and responses: measurement and reporting. Gut 2004;53:iv45–8.
   PubMed Web of Science ®Google Scholar
• Wong BCY, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398–407.
   PubMed Web of Science ®Google Scholar
• Rentz AM, Battista C, Trudeau E, Jones R, Robinson P, Sloan S, Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature. Pharmacoeconomics 2001;19:349–63.
   PubMedGoogle Scholar
• Dent J. Review article: towards the optimization of symptom evaluation in reflux disease. Aliment Pharmacol Ther 2004;20:14–18; discussion 38–9.
   PubMedGoogle Scholar
• Spechler SJ, Jain SK, Tendler DA, Parker RA. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002;16:1795–800.
   PubMed Web of Science ®Google Scholar
• Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023–9.
   PubMed Web of Science ®Google Scholar
• Vakil N, van Zanten SV, Chang L, Toth G, Sherman J, Fraser M, Comprehension and awareness of symptoms in women with dyspepsia. Aliment Pharmacol Ther 2005;22:1147–55.
   PubMedGoogle Scholar
• Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors. Scand J Gastroenterol 2000;35:142–51.
   PubMedGoogle Scholar
• Wong WM, Lam KF, Lai KC, Hui WM, Hu WH, Lam CL, A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1407–13.
   PubMedGoogle Scholar
• Armstrong D, Veldhuyzen SJ, Chung SA, Shapiro CM, Dhillon S, Escobedo S, Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test. Can J Gastroenterol 2005;19:350–8.
   PubMedGoogle Scholar
• Stanghellini V, Tosetti C, Paternico A, De Giorgio R, Barbara G, Salvioli B, Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999;94:2080–5.
   PubMed Web of Science ®Google Scholar
• Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52–7.
   PubMed Web of Science ®Google Scholar
• Yang SY, Lee OY, Bak YT, Jun DW, Lee SP, Lee SH, Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci 2008;53:188–93.
   PubMed Web of Science ®Google Scholar
• Pilotto A, Maggi S, Noale M, Franceschi M, Parisi G, Crepaldi G. Development and validation of a new questionnaire for the evaluation of upper gastrointestinal symptoms in the elderly population: a multicenter study. J Gerontol A Biol Sci Med Sci 2010;65:174–8.
   PubMedGoogle Scholar
• Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724–35.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures. Qual Life Res 2005;14:21–33.
   PubMedGoogle Scholar
• Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci 2001;46:1540–9.
   PubMedGoogle Scholar
• Jones RH, Hungin AP, Phillips J, Mills JG. Gastro-oesophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findings. Eur J Gen Pract 1995;1:149–54.
   Google Scholar
• Pilotto A, Franceschi M, Leandro G, Scarcelli C, D'Ambrosio LP, Seripa D, Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc 2006;54:1537–42.
   PubMed Web of Science ®Google Scholar
• Anastasiou F, Antonakis N, Chaireti G, Theodorakis PN, Lionis C. Identifying dyspepsia in the Greek population: translation and validation of a questionnaire. BMC Public Health 2006;6:56.
   PubMedGoogle Scholar
• Chassany O, Marquis P, Scherrer B, Read NW, Finger T, Bergmann JF, Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999;44:527–33.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999:II37–42.
   Google Scholar
• Spiegel BM, Bolus R, Agarwal N, Sayuk G, Harris LA, Lucak S, Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. Aliment Pharmacol Ther 2010;32:1275–91.
   PubMed Web of Science ®Google Scholar
• Vakil N, Malfertheiner P, Salis G, Flook N, Hongo M. An international primary care survey of GERD terminology and guidelines. Dig Dis 2008;26:231–6.
   PubMedGoogle Scholar
• Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) – a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–20.
   PubMed Web of Science ®Google Scholar
• Society of American Gastrointestinal Endoscopic Surgeons S. Guidelines for surgical treatment of gastroesophageal reflux disease (GERD). Surg Endosc 1998;12:186–8.
   Google Scholar
• Trentacosti AM, He R, Burke LB, Griebel D, Kennedy DL. Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design. Am J Gastroenterol 2010;105:731–5.
   PubMedGoogle Scholar
• Booth MI, Stratford J, Dehn TC. Patient self-assessment of test-day symptoms in 24-h pH-metry for suspected gastroesophageal reflux disease. Scand J Gastroenterol 2001;36:795–9.
   PubMed Web of Science ®Google Scholar
• Dent J, Kahrilas PJ, Vakil N, Veldhuyzen van Zanten S, Bytzer P, Delaney B, Clinical trial design in adult reflux disease – a methodological workshop. Aliment Pharmacol Ther 2008;28:107–26.
   PubMedGoogle Scholar
• Svedlund J, Sjodin I, Dotevall G. GSRS – a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129–34.
   PubMed Web of Science ®Google Scholar
• Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005;8:94–104.
   PubMed Web of Science ®Google Scholar
• Flook NW, Wiklund I. Accounting for the effect of GERD symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians. Int J Clin Pract 2007;61:2071–8.
   PubMedGoogle Scholar
• Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health 2009;12:419–29.
   PubMed Web of Science ®Google Scholar
• Patient Reported Outcomes Measurement Information System (PROMIS): National Institutes of Health. 2012. Available from http://www.nihpromis.org/default (Accessed 12 June 2012).
   Google Scholar